Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


IJTRR. 2016; 5(4): 63-69

Aerobic exercise in obese type 2 diabetic patients: Effect on plasminogen activator inhibitor 1 and visfatin levels

Rania Abdel Basit Abdel Moez, Akram Abdel Azez Said.

Background: obese type 2 diabetic patients have higher visceral adiposity than others, and thus more adipokines activity, which in turn affect whole body metabolism and cause multiple complications and consequences such as cardiovascular disease and insulin resistance. Purpose of the Study: To investigate the effect of Aerobic exercise on plasminogen activator inhibitor 1 (PAI 1) and visfatin levels in obese diabetic patients. Subjects and Methods: Thirty obese diabetic patients from both ganders, aged from 40 to 55 years old were enrolled in this study. They were randomly assigned to Group (A) and Group (B), 15 patients each .Group (A) received aerobic exercise in form of stationary bicycle in addition to their traditional medication , while Group( B) received their traditional medication only.. PAI 1 and Visfatin levels were evaluated before and after treatment period by using ELISA reader. Results: Improvement of PAI 1 and Visfatin were observed in the study group at the end of the study (P-value < 0.05) with no change in the control group (P-value > 0.05). On comparing the mean values of PAI 1 and Visfatin between both groups a statistical significant difference was observed (P-value < 0.05) at the end of the study in favor of the study group with 41.48% and 2.99% decrease in PAI 1 and 35.73% and 4.52% decrease in Visfatin in study and control group respectively. Conclusion: Aerobic exercise is beneficial on lowering PAI 1 and Visfatin in obese diabetic patients, and hence decreases the risk of cardiovascular disease and insulin resistance in obese diabetic patients.

Key words: Adipokines, Diabetes mellitus type 2, obesity, aerobic exercise.

Share this Article

Progress in Orthopedic Science


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons